Altier Christophe, Zamponi Gerald W
Hotchkiss Brain Institute, Department of Physiology and Biophysics, University of Calgary, Canada.
J Recept Signal Transduct Res. 2008;28(1-2):71-81. doi: 10.1080/10799890801941947.
Activation of opioid or opioid-receptor-like (ORL1 a.k.a. NOP or orphanin FQ) receptors mediates analgesia through inhibition of N-type calcium channels in dorsal root ganglion (DRG) neurons (1, 2). Unlike the three types of classical mu, delta, and kappa opioid receptors, ORL1 mediates an agonist-independent inhibition of N-type calcium channels. This is mediated via the formation of a physical protein complex between the receptor and the channel, which in turn allows the channel to effectively sense a low level of constitutive receptor activity (3). Further inhibition of N-type channel activity by activation of other G protein-coupled receptors is thus precluded. ORL1 receptors, however, also undergo agonist-induced internalization into lysosomes, and channels thereby become cointernalized in a complex with ORL1. This then results in removal of N-type channels from the plasma membrane and reduced calcium entry (4). Similar signaling complexes between N-type channels and GABA(B) receptors have been reported (5). Moreover, both L-type and P/Q-type channels appear to be able to associate with certain types of G protein-coupled receptors (6, 7). Hence, interactions between receptors and voltage-gated calcium channels may be a widely applicable means to optimize receptor channel coupling.
阿片类或阿片受体样(ORL1,又称NOP或孤啡肽FQ)受体的激活通过抑制背根神经节(DRG)神经元中的N型钙通道介导镇痛作用(1, 2)。与三种经典的μ、δ和κ阿片受体不同,ORL1介导对N型钙通道的非激动剂依赖性抑制。这是通过受体与通道之间形成物理蛋白质复合物来介导的,这反过来又使通道能够有效地感知低水平的组成型受体活性(3)。因此,其他G蛋白偶联受体的激活对N型通道活性的进一步抑制被排除。然而,ORL1受体也会在激动剂诱导下内化到溶酶体中,通道因此与ORL1形成复合物共同内化。这进而导致N型通道从质膜上移除,钙内流减少(4)。已报道N型通道与GABA(B)受体之间存在类似的信号复合物(5)。此外,L型和P/Q型通道似乎都能够与某些类型的G蛋白偶联受体结合(6, 7)。因此,受体与电压门控钙通道之间的相互作用可能是优化受体通道偶联的一种广泛适用的手段。